Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Donna

Donna Armentano, Cambridge, MA US

Patent application numberDescriptionPublished
20090162345Materials and Methods for Reversing Type-1 Diabetes - In accordance with the subject invention, anti-thymocyte globulin (ATG) can be used to modulate a patient's immune response in order to prevent and/or delay the onset or the progression of type 1 diabetes. ATG treatment augments CD4+CD25+ cell frequencies and their functional activities.06-25-2009
20100322894Combination Therapies for Treating Type 1 Diabetes - In accordance with the subject invention, combination therapies can be used to modulate a patient's immune response in order to prevent, delay and/or reverse type 1 diabetes.12-23-2010

Donna Armentano, Belmont, MA US

Patent application numberDescriptionPublished
20110212529Muscle-specific expression vectors - The invention is directed to novel combinations of muscle-specific enhancers and promoter elements useful for achieving persistent expression in the muscle or myocyctes. The muscle-specific promoter elements are derived from a muscle creatine kinase promoter, a troponin I promoter, a skeletal alpha-actin promoter, or a desmin promoter. The muscle-specific enhancer elements are derived from either troponin I internal regulatory elements, muscle creatine kinase enhancers, or desmin enhancers.09-01-2011

Donna Baker Schwenk, Rockport, MA US

Patent application numberDescriptionPublished
20080231210REMOTE-CONTROLLED DECORATION - A remote-controlled decoration includes a decorative main body and a remote controller. The decorative main body includes an internal chamber, and a base mounted to a lower open end of the chamber. The base is provided with a circuit board connected to a power source, at least one LED light, and a receiver. The remote controller includes a signal transmitter for remotely transmitting a control signal to the receiver on the decorative main body, so as to control the LED light to light or extinguish.09-25-2008

Donna Cabral-Lilly, Pennington, NJ US

Patent application numberDescriptionPublished
20090098196LIPID CARRIER COMPOSITIONS WITH REDUCED POLY-DISPERSITY - The invention relates to a method for reducing the polydispersity of a population of gel-phase lipid-based delivery vehicles.04-16-2009

Donna Cabral-Lilly, Princeton, NJ US

Patent application numberDescriptionPublished
20090068256Encapsulation of Bioactive Complexes in Liposomes - This invention provides a method to prepare liposome-encapsulated bioactive agents, such as nucleic acids, comprising complexation of the bioactive agents to reverse micelles prior to forming liposomes, as well as methods of using the liposomes so formed and formulations to deliver nucleic acids to cells.03-12-2009

Donna Cassidy-Hanley, Ithaca, NY US

Patent application numberDescriptionPublished
20120129217POLYPEPTIDE EXPRESSION IN CILIATES - This invention is directed to methods for recombinant polypeptide production and, in particular, methods and products for the production of recombinant polypeptides in ciliates.05-24-2012

Donna Daem, Bellevue, WA US

Donna Davies, Salisbury GB

Patent application numberDescriptionPublished
20090004139INTERFERON-BETA AND/OR LAMBDA FOR USE IN TREATING RHINOVIRUS INFECTION IN THE ELDERLY - Use of interferon-beta (IFN-β) and/or IFN-λ for treating rhinovirus (RV) infection in elderly people, particularly elderly people who are, or have been long-term smokers, especially those who have a clinical history of recurrent RV infections, and may have other medical conditions, such as cardiac or circulation problems, and who are liable to suffer severe complications/high mortality from poor innate ability to fight such a viral infection.01-01-2009
20110177028INTERFERON-BETA AND/OR LAMBDA FOR USE IN TREATING RHINOVIRUS INFECTION IN THE ELDERLY - Use of interferon-beta (IFN-β) and/or IFN-λ for treating rhinovirus (RV) infection in elderly people, particularly elderly people who are, or have been long-term smokers, especially those who have a clinical history of recurrent RV infections, and may have other medical conditions, such as cardiac or circulation problems, and who are liable to suffer severe complications/high mortality from poor innate ability to fight such a viral infection.07-21-2011

Donna Dearinger, San Jose, CA US

Patent application numberDescriptionPublished
20100084074TRANSPARENT BREATHABLE POLYURETHANE FILM FOR TATTOO AFTERCARE AND METHOD - One aspect is a method of tattoo aftercare including preparing a cover assembly for application over a newly-created tattoo. A film is applied over the tattoo and the film is left in place over the tattoo for at least 12 hours.04-08-2010

Donna Dobinson, Hertfordshire GB

Patent application numberDescriptionPublished
20110105422USE OF G-RICH OLIGONUCLEOTIDES FOR TREATING NEOPLASTIC DISEASES - The invention relates to methods of treating patients (either adult or paediatric) with tumours using G rich oligonucleotides. In embodiments of the invention, methods of treating patients with tumours using a combination of G rich oligonucleotides and a chemotherapeutic agent are provided. There are also provided pharmaceutical compositions and kits for use in the methods of the invention.05-05-2011

Donna Eiby, Potts Point AU

Patent application numberDescriptionPublished
20080270214System and Process for Managing the Preparation of a Bid Document in Response to a Tender - A system for managing the preparation of a bid document in response to a tender receives clauses selected from a tender document and categorises each clause into one of a plurality of clause categories. An author association component of the system associates each clause categorised as a response requirement with a response author. A messaging component sends a response template including at least one response requirement to an associated response author, and receives the completed response template from the response author. A bid document generator generates a bid document on the basis of the response text received from response authors.10-30-2008

Donna Figlik, Chicago, IL US

Patent application numberDescriptionPublished
20090287613AUTOMATED ACTIONS BASED ON RESTRICTIONS - A technique for resolving a violation of an investment account restriction is provided. The restriction is associated with the holding of one or more securities in an investment account. A restriction definition and an associated resolution rule are stored in a data repository. A received order to perform an investment account management action is processed to determine that performance of the action violates the stored restriction definition. The associated resolution rule is then retrieved based upon the determination and then executed. Indications of the determined violation and of the executed resolution rule are stored in the data repository.11-19-2009

Patent applications by Donna Figlik, Chicago, IL US

Donna Floros, Palm Springs, CA US

Patent application numberDescriptionPublished
20090303533ADVERTISING APPARATUS WITH HOOK - A hook apparatus includes a front side and a back side. A hook extending from the front side is included for hanging objects. A shelter structure extends from the front side positioned around and apart from the hook. The shelter structure may serve as a second hook for hanging objects. A communications device extends from the body, at least a portion of which is above and spaced apart from the shelter structure. The back side of the hook apparatus is adapted to be secured to a surface. An interface adapter plate between the back side and the mounting surface may be provided to enable the securing. The communications device includes a display device that is either passive or capable of interactive communication of information. The apparatus may be operationally coupled to a remote server to alert vendors to deliver purchased products, services, and/or to provide emergency services to the user.12-10-2009

Donna Hougland, Portland, OR US

Patent application numberDescriptionPublished
20100011592Method for feeding a child during the child's transition from bottle- to spoon-feeding - A method for feeding a child, the child having a mouth, the child having a transition from bottle-to spoon-feeding, the child having a natural swallowing reflex, the method for use during that transition, the method with respect to a spoon having a handle a bowl, the bowl having an end away from the handle thus defining an anterior end, the bowl having an end toward the handle thus defining a posterior end, the method comprising the steps of: covering a front portion of a spoon bowl by an enclosing shield so that that it leaves an opening at a posterior of the spoon bowl and at an anterior of the spoon bowl.01-21-2010

Patent applications by Donna Hougland, Portland, OR US

Donna Huryn, Allenton, NJ US

Patent application numberDescriptionPublished
20110207726Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S - The present invention is directed to novel protease inhibitors that are specific for cathepsin L, cathepsin B, and cathepsin S. Accordingly, the present invention encompasses compositions and methods for treating and preventing diseases and disorders associated with cathepsin L, cathepsin B, or cathepsin S function or activity.08-25-2011

Donna Kasseinova, Palos Verdes Estates, CA US

Patent application numberDescriptionPublished
20110213183METHOD FOR PREPARING SUCCINIC ACID - A method for preparing succinic acid, including producing a modified palladium-containing catalyst by using an acid and liquid-phase hydrogenation of unsaturated acid compounds on the modified catalyst at an increased temperature and pressure; separating the catalyst from the succinic acid; wherein the modification of the catalyst is performed on a substrate having the palladium-containing catalyst delivered thereon, the delivery being performed in an oxygen-free atmosphere; the delivery being performed in an aqueous medium of succinic, maleic or fumaric acids and/or their mixtures at a Pd09-01-2011
20120130125METHOD FOR PREPARING AMMONIUM SALTS OF FUMARIC OR SUCCINIC ACID - An improved process for preparing ammonium salts from fumaric or succinic acid, is described. The method consists of neutralizing the corresponding acid carbonate or ammonium bicarbonate at a molar stoichiometric or greater than the stoichiometric ratio of 4-5% in a saturated aqueous solution of the synthesized salt at a temperature not exceeding 40° C., followed by separation of the product and drying at a temperature not exceeding 70° C. After separation of the ammonium salts, the filtrate can be re-used. Isolation of the product is usually carried out by cooling the reaction mixture to a temperature of 15-18C°. The product comes out in almost crystalline form. Saturated aqueous solution of the synthesized salt is formed by the interaction of carbonate or ammonium bicarbonate with the appropriate acid at a temperature not exceeding 40° C. It is possible to obtain cleaner salt concentration weighing more than 99% and not yielding lower than 98%. The method allows for an increase in the yield of targeted products and ensures their consistent high quality due to their formation in crystalline form.05-24-2012

Donna Klinzman, Coralville, IA US

Patent application numberDescriptionPublished
20090010932GB VIRUS C (HEPATITIS G VIRUS) FOR THE TREATMENT OF HIV - GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving an anti-GBV-C antibody or other GBV-C binding agent, or a GBV-C antigen, for inhibiting and treating HIV infections.01-08-2009

Donna Kotzer Jacobs, Toronto CA

Patent application numberDescriptionPublished
20090088045PLUSH TOY - A plush toy has a stuffed fabric shell having at least one shell piece with an orifice closed by a releasable fastener. A stuffing pouch stuffed with filling and having a shape generally corresponding the shell piece can be removed from and replaced in the shell to allow the shell piece to be embroidered.04-02-2009

Donna Lim, Taipei TW

Patent application numberDescriptionPublished
20100287395COMPUTER SYSTEM FOR PROCESSING DATA IN NON-OPERATIONAL STATE AND PROCESSING METHOD THEREOF - A computer system for processing data in a non-operational state and processing method thereof are provided. The computer system includes a data output unit, a data source, a data processing module and a state monitor unit. The data processing module accesses and processes data from the data source, and transmits the processed data to the data output unit. The state monitor unit monitors a power supply state of the computer system to generate a state switch signal, which indicates whether the computer system is in an operational state or a non-operational state. When the state switch signal indicates that the computer system is in a non-operational state, the data source and the data processing module receives operating voltages to access and process data.11-11-2010

Donna Livant, Ann Arbor, MI US

Patent application numberDescriptionPublished
20090075905Anticancer compounds and methods - The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.03-19-2009
20100292173Wound Healing Compounds And Methods - The testing of tumor cells, including human tumors capable of metastases, in assays employing fibronectin-depleted substrates is described. Ex vivo induction of cells, including biopsied human cells, is performed with invasion-inducing agents. Additionally, anti-cancer chemotherapeutics are described. Specifically, chemotherapeutic agents which have anti-metastatic and anti-growth properties are described including non-peptide compositions of matter.11-18-2010
20120077755Compounds For, and Methods of, Treating Cancer and Inhibiting Invasion and Metastases - Invasion-inhibiting peptides comprising either a modified cysteine (where the sulfur atom is modified with a alkyl group or other suitable group), and/or b) D-amino acids, for the treatment “cancer” in humans and animals. Such peptides can be used together with other therapies (e.g. radiation) to enhance the therapeutic benefit and reduce invasiveness.03-29-2012

Patent applications by Donna Livant, Ann Arbor, MI US

Donna Mcelyea, Hot Springs, AR US

Patent application numberDescriptionPublished
20120013164Child relaxation accessory - An accessory for enticing a child to rest and relax during the course of a trip in a motor vehicle. The accessory is attached to, and stabilized on the back of, the back seat of the vehicle and provides a head rest in the form of a cuddly animal or the like against which the child can rest and relax its head during the trip.01-19-2012

Donna Mellion, Jacksonville, FL US

Patent application numberDescriptionPublished
20110017793ADAPTABLE WEARABLE FLEXIBLE TUBULAR CARRIER AND TRAVEL PILLOW - A flexible tubular carrier is suitable for storing one or more items such as garments and configured to be carried using a strap, attachable to other carriers, wearable around one's neck or waist and usable as a lumbar or neck pillow. Additionally, the carrier is easy to load. The carrier features a flexible tubular body, opposite flexible end covers, and angled zipper closures adjoining the end covers to the tubular body. Items such as garments may be rolled and inserted and pulled into the tubular container. Straps and connectors are provided to wear the carrier over one's shoulder or around one's neck or waist and to attach the carrier to other carriers. When filled with relatively soft items, such as rolled-up garments, the carrier may be bent into a horseshoe shape, secured around one's neck and comfortably worn as a cushion and head support. Alternatively, the carrier may be worn around one's lower back to provide lumbar support and cushioning. Additionally, the carrier may be worn over one's shoulder and used as a cushioned strap to support another carrier. Uniquely angled zippers facilitate easy access to stored items. When opened, at least one zipper reveals a drop-down pocket attached to the interior of the container.01-27-2011

Donna Millette, Chester, NH US

Patent application numberDescriptionPublished
20080311357LAMINATE CONSTRUCTION CONTAINING DISCONTINUOUS METAL LAYER - A sheetstock having a bright metallic appearance, especially useful as signage, badging, automotive trim and appliance trim, is provided by applying an island coating system on the second surface of a transparent or translucent sheetstock. The island coating system may comprise a clear layer, a discontinuous metal layer and a backing layer. The sheetstock and/or clear layer may be colored, printed upon or contain decorative particles to enhance the appearance.12-18-2008

Donna Newman-Bluestein, Newton, MA US

Patent application numberDescriptionPublished
20080224412Apparatus and method to facilitate group exercise and movement - An apparatus and method are disclosed for facilitating group movement activities. The apparatus includes a set of arms that extend radially outward from a central area. In use, a group of participants arranged in a circle around the central area each grasp at least one of the arms at a suitable point along its length, and the participants pull on the arms so as to cause the central area to move in a desired manner. The central area can be integral with the arms, or can be a distinct object, such as a disk or a polygon, with the arms attached symmetrically around its perimeter. Graphics can be applied to the surface of the central area. Bells and/or other objects that make sounds when moved can be attached to the arms. A handle and/or a cuff can be attached to the end of each arm to aid in holding it.09-18-2008

Donna Oksenberg, Palo Alto, CA US

Patent application numberDescriptionPublished
20100081632High-content and high throughput assays for identification of lipid-regulating pathways, and novel therapeutic agents for lipid disorders - A method of assaying protein-protein interactions associated with proteins involved in lipid pathways using a protein fragment complementation assays, said method comprising the steps of: (a) identifying protein molecules that interact with said protein associated with lipid pathways; (b) selecting a protein reporter molecule; (c) effecting fragmentation of said protein reporter molecule such that said fragmentation results in reversible loss of reporter function; (d) fusing or attaching fragments of said protein reporter molecule separately to said interacting protein molecules as defined in step (a); (e) transfecting cells with nucleic acid constructs coding for the products of step (d); (f) reassociating said reporter fragments through interactions of the protein molecules that are fused or attached to said fragments; and (g) measuring directly or Indirectly the activity of said reporter molecule resulting from the reassociation of said reporter fragments.04-01-2010
20110015209Sigma ligands for neuronal regeneration and functional recovery - The invention discloses methods and compositions useful for facilitating neuronal regeneration and functional recovery in neurodegenerative diseases. The methods and compositions utilize ligands for the sigma receptor, wherein the ligand is preferably AGY-94806, or salts, or solvates thereof. These molecules can be delivered alone or in combination with agents which treat or prevent neurodegenerative diseases such as those caused by multiple sclerosis. In other methods, the sigma receptor ligands are administered after MS to facilitate functional recovery. The administration of the sigma receptor ligands causes fasted functional recovery.01-20-2011
20110082154Sigma ligands for neuronal regeneration and functional recovery - The invention discloses methods and compositions useful for facilitating neuronal regeneration and functional recovery in neurodegenerative diseases. The methods and compositions utilize ligands for the sigma receptor, wherein the ligand is preferably SA-4503, or salts, or solvates thereof. These molecules can be delivered alone or in combination with agents which treat or prevent neurodegenerative diseases such as those caused by ischemic stroke, diabetic peripheral neuropathy, cancer therapy induced neuropathy, multiple sclerosis, amyotrophic lateral sclerosis, traumatic brain injury, spinal cord injury, Huntington's disease or Parkinson's disease. In other methods, the sigma receptor ligands are administered after stroke to facilitate functional recovery. The administration of the sigma receptor ligands effects faster functional recovery.04-07-2011
20110152284Sigma ligands for neuronal regeneration and functional recovery - The invention discloses methods and compositions useful for facilitating neuronal regeneration and functional recovery in neurodegenerative diseases. The methods and compositions utilize ligands for the sigma receptor, wherein the ligand is preferable AGY-94806, or salts or solvates thereof. These molecules can be delivered alone or in combination with agents which treat or prevent neurodegenerative diseases such as those caused by ischemic stroke, multiple sclerosis, amyotrophic lateral sclerosis, traumatic brain injury, Huntington's disease, or Parkinson's disease. In other methods, the sigma receptor ligands are administered after stroke to facilitate functional recovery. The administration of the sigma receptor ligands effects functional recovery.06-23-2011

Patent applications by Donna Oksenberg, Palo Alto, CA US

Donna Peehl, Stanford, CA US

Patent application numberDescriptionPublished
20090105343Cancer Therapy And Medicaments Therefor - The present invention relates to a novel cancer therapy, particularly, but not exclusively, to a prostate, bladder and breast cancer therapy and to Compositions and medicaments for use in said therapy. In one aspect there is provided a method of treating a patient afflicted with cancer comprising administering to the patient a therapeutically effective amount of a nuclear receptor ligand and an HDAC (histone deacetylases) inhibitor wherein said nuclear receptor ligand is not a ligand for the vitamin D receptor.04-23-2009

Donna Robinson-Hahn, Center Valley, PA US

Patent application numberDescriptionPublished
20080253046UN-ASSISTED, LOW-TRIGGER AND HIGH-HOLDING VOLTAGE SCR - A protective SCR integrated circuit device is disclosed built on adjacent N and P wells and defining an anode and a cathode. In addition to the anode and cathode contact structures, the device has an n-type stack (N+/ESD) structure bridging the N-Well and the P-Well, and a p-type stack (P+/PLDD) structure in the P-Well. The separation of the n-type stack structure and the p-type stack structure provides a low triggering voltage, that together with other physical dimensions and processing parameters also provide a relatively high holding voltage. In an embodiment, the triggering voltage may be about 8V while exhibiting a holding voltage, that may be controlled by the lateral dimension of the n-type stack of about 5-7 V.10-16-2008

Donna Sardanopoli, Allendale, NJ US

Patent application numberDescriptionPublished
20110209197WEB-BASED AUDIT SYSTEM AND RELATED AUDIT TOOL - A web-based audit system and related tool implemented by a computer or personal digital assistant providing user with access to the internet, comprising access to a repository of audit content; wherein said audit content is associated with appropriate regulatory rules, notices policies and information ; a means to update said regulatory rules, notices, policies and information associated with said audit content with changes.08-25-2011

Donna Tellam, Superior, CO US

Patent application numberDescriptionPublished
20090063221System, method and computer program product for generating key performance indicators in a business process monitor - A system, method and computer program product to enable graphical modeling of business processes. KPIs may be defined as part of the design procedure of forming the process. Once defined, the definitions of the KPIs may be included in deployable units and provided to a runtime environment.03-05-2009

Donna Tomky, Albuquerque, NM US

Patent application numberDescriptionPublished
20080268412Method for Improving Patient Chronic Disease Education - A method to determine, monitor, evaluate, and improve the effectiveness of self-management education for patients with a chronic disease. The present disclosure discloses that the effectiveness of a patient self-management education program can be determined and improved by evaluating specific standardized patient outcomes at standardized intervals, in particular by evaluating behavior changes in the patient receiving the education.10-30-2008

Donna Une, Garden Grove, CA US

Patent application numberDescriptionPublished
20110018895Color Selection, Coordination and Purchase System - A paint color selection website arranged to provide a plurality of home pages each comprising a featured project image, each project image employing a plurality of different colors, each color located in a respective region of the image with at least one “hot spot” located in one or more of the regions, each hot spot comprising an attention-drawing animation feature responsive to a first selection operation to cause display of at least one color name, the color name being that of the color of the region where the hot spot lies. The home pages further may include real-life simulating animation features while the system software is operable to select the relative frequency with which each home page appears in response, for example, to a user's successive home page selections. An animated color sheen selection tool is also provided.01-27-2011
20110018896Automated Color Selection Method and Apparatus - An automated method and apparatus for providing color selection capability to a user wherein a first display is generated on a display apparatus of an array of color family groups disposed in a plurality of rows and a plurality of columns. Upon selection of a particular color family group, a second display is generated comprising an enlarged display of a particular selected color family group wherein, as the second display is generated, the array of color family groups of the first display dissolves while the particular selected color family group moves into a central enlarged position and a miniature version of the entire array of color family groups is displayed in a thumbnail navigation frame, located in a corner of the display screen. Various elements of a color family such as color stripe cards, color style cards, and sample chips may be selected and caused to appear via animation in a central enlarged position in the display.01-27-2011

Donna Yu, Arcadia, CA US

Patent application numberDescriptionPublished
20090176305COMPOUNDS AND METHODS FOR TREATING BREAST CANCER AND OTHER DISEASES - Disclosed are novel compositions and novel methods for the creation of both the novel compounds and known compounds. Also disclosed are methods for use of the novel compounds for treating a variety of diseases relating to decreasing or preventing activation of estrogen receptors and/or estrogen related receptors.07-09-2009
20090318693LIGANDS FOR ESTROGEN RELATED RECEPTORS AND METHODS FOR SYNTHESIS OF SAID LIGANDS - Estrogen-Related Receptor (ERR) modulating compounds and methods for synthesis of said compounds are described.12-24-2009

Patent applications by Donna Yu, Arcadia, CA US